-

Viz.ai Wins Four Comparably Awards for Best Place to Work

Healthcare technology leader recognized for its culture, diversity, career growth and outlook

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022. Earlier this year, the Company was also awarded Best Company Outlook and Best Company Career Growth, bringing its total to four Comparably awards.

“We are honored to receive these distinguished awards as they are a true testament to our people-centric business built on kindness and collaboration. Viz.ai is uniquely positioned to increase access to life-saving treatments through the power of artificial intelligence and our broad hospital network, so it’s important our employees feel encouraged and supported in all aspects of life,” said Chris Mansi, CEO at Viz.ai. “I would like to extend my deepest gratitude to those who participated in the Comparably ratings. Your feedback is imperative to the ongoing improvements of our workplace experience.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final dataset was compiled from 15 million ratings across 70,000 large and small U.S. companies. Viz.ai’s Employee Net Promoter Score (eNPS) was 72, which is in the top 10 percent of 1,670 similarly-sized companies.

“Viz.ai has quickly become a leader in using artificial intelligence to expedite disease detection and care, but this wouldn’t be possible without the dedication of our passionate and hard-working team,” said Dawn Sprague, vice president of people at Viz.ai. “Building a workplace environment that nurtures each individual’s identity, goals, and career path ensures our employees come to work energized to create and deliver solutions that inform critical care decisions, helping improve patient lives.”

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Erich Sandoval
erich.sandoval@finnpartners.com
+1 917 497 2867

Viz.ai


Release Versions

Contacts

Erich Sandoval
erich.sandoval@finnpartners.com
+1 917 497 2867

Social Media Profiles
More News From Viz.ai

New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of Hypertrophic Cardiomyopathy

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how Viz HCM enables faster, accurate detection of hypertrophic cardiomyopathy (HCM), to help ensure that more patients are identified. Two studies, which will be presented at the American Heart Association (AHA) Scientific Sessions 2025, show Viz.ai’s real-world ability to identify more patients with HCM years earlier than current...

Viz.ai Launches Viz Assist: The First Multimodal AI Agent Platform for Faster Treatment and Better Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz Assist™, a suite of autonomous AI agents that significantly enhance how care teams identify, prioritize, and act on critical patient data.1 Viz Assist marks a major step forward in Viz.ai’s mission to use technology to reduce time to treatment and improve patient outcomes. Viz Assist incorporates inputs from ambient listening and the electronic...

Viz.ai Launches Viz ACS™ to Accelerate Treatment for Heart Attack and Reduce Unnecessary Activations

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz ACS, a new solution in the Viz Cardio™ Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and re...
Back to Newsroom